EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022

EpiCast Report: Multiple Sclerosis Epidemiology Forecast to 2022

Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and symptoms. MS affects 2.5 million people worldwide each year and is the most debilitating neurological disease in young adults (Fernandes de Abreu et al., 2009). In 2012, the US had the highest number of prevalent and incident cases among the 10 markets, and will continue to comprise the largest portion of the market until 2022. Western countries in the analysis had a higher number of prevalent cases in 2012 than did Asian countries (India, China, and Japan); however, this was not true for incident cases. In 2012, China had more incident cases than all countries except the US, and India had a higher number of incident cases than Italy, Spain, and Japan. The prevalence and incidence of MS vary greatly by age, gender, and geographical location. Regional differences in MS prevalence and incidence could be due to several factors including diagnostic criteria used, availability of medical technology, genetic and environmental risk factors, frequency of comorbidities, and population age and gender structure.

 

Scope

• The Multiple Sclerosis EpiCast Report and EpiCast Model provide an overview of the risk factors and global trends of multiple sclerosis.
• Data is provided for eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and Canada) in addition to emerging markets India and China. 
• It includes a 10-year epidemiological forecast of multiple sclerosis prevalence and incidence segmented by gender, age (in five-year increments beginning at 20 years and ending at =85 years), and multiple sclerosis subtypes in 10 markets.

 To purchase and know more about this market research reports please visit: http://www.marketresearchreports.com/globaldata/epicast-report-multiple-sclerosis-epidemiology-forecast-2022

  

Reasons to buy

• Develop business strategies by understanding the trends shaping and driving the global multiple sclerosis market.
• Quantify patient populations in the global multiple sclerosis market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the age groups, gender, and subtypes that present the best opportunities for multiple sclerosis therapeutics in each of the markets covered.